Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan · Delayed Price · Currency is TWD 34.25
-0.10 (-0.29%)
Sep 8, 2026, 1:30 PM CST
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 3.06 billion as of September 8, 2026. Its market cap has decreased by -3.98% in one year.
Market Cap
3.06B
Enterprise Value
2.44B
Revenue
1.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.25
ChartMarket Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 3.06B, a decrease of -55.05%. That is a compound annual growth rate of -6.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 3.06B | -21.98% |
| Dec 31, 2025 | 3.92B | 1.15% |
| Dec 31, 2024 | 3.88B | -14.54% |
| Dec 29, 2023 | 4.54B | -11.69% |
| Dec 30, 2022 | 5.14B | -44.90% |
| Dec 30, 2021 | 9.33B | -53.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.35B |
| BRIM Biotechnology | 3.35B |
| OBI Pharma | 3.28B |
| Shine-On BioMedical | 3.20B |
| Apex Biotechnology | 3.17B |
| Great Novel Therapeutics Biotech & Medicals | 3.15B |
| Sagittarius Life Science | 3.12B |